Skip to main content
ClouDr Group Limited logo

ClouDr Group Limited — Investor Relations & Filings

Ticker · 9955 LEI · 549300G47ND4IU8K6324 HKEX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 170 across all filing types
Latest filing 2022-06-23 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 9955

About ClouDr Group Limited

http://www.cloudr.cn

ClouDr Group Limited is a digital chronic condition management solution provider, recognized as the largest in China by the number of Software-as-a-Service (SaaS) installations. The company operates an innovative digital healthcare ecosystem designed to manage chronic diseases and integrate digital health services across the medical supply chain. ClouDr supplies medical supplies and SaaS products to hospitals and pharmacies, while also offering digital marketing services to pharmaceutical companies. Core platforms include the ClouDr SaaS System for Hospitals and the ClouDr Pharmacy Solution for compliant prescription management. The ecosystem connects patients and professionals via the ClouDr Mini Program, which facilitates remote follow-up, medication delivery, and customized chronic disease management plans, and the Dr. ClouDr platform, which enables physicians to efficiently manage patient data and optimize treatment protocols.

Recent filings

Filing Released Lang Actions
GLOBAL OFFERING
Regulatory Filings
2022-06-23 English
PHIP (1st submission)
Audit Report / Information Classification · 1% confidence The document is a 'PHIP' (Preliminary Hearing Information Document) from the Hong Kong Stock Exchange (HKEX). A PHIP is a standard document filed by companies in Hong Kong during the IPO process, serving as a preliminary prospectus. Among the provided categories, 'POS' (Transaction in Own Shares) or 'SHA' (Share Issue/Capital Change) are not appropriate for an IPO prospectus. Given the structure of the document (listing sections like 'Business', 'Financial information', 'Directors', and 'Accountants' Report'), it represents the core offering document for a public listing. Since there is no specific 'IPO Prospectus' category, and it is a regulatory filing for a public offering, 'RNS' (Regulatory Filings) is the most appropriate fallback category. FY 2021
2022-06-13 English
PHIP (1st submission)
Regulatory Filings
2022-06-13 English
Application Proof (1st submission)
Regulatory Filings Classification · 1% confidence The document is an 'Application Proof' for ClouDr Group Limited, which is a standard term used in the Hong Kong Stock Exchange (HKEX) listing process for an initial public offering (IPO). The document contains sections typical of a prospectus, such as 'Industry overview', 'Business', 'Financial information', and 'Accountants' Report'. Since it is an application proof for a listing, it falls under the category of regulatory filings related to capital raising or IPOs. Given the specific options provided, 'RNS' (Regulatory Filings) is the most appropriate fallback category for this type of pre-listing disclosure document.
2022-02-28 English
Application Proof (1st submission)
Regulatory Filings
2022-02-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.